免疫联合靶向治疗原发性肝细胞肝癌 合并胆管癌栓术后复发的临床疗效

Clinical efficacy of immunotherapy plus targeted therapy in the treatment of postoperative recurrence for hepatocellular carcinoma with bile duct tumor thrombus

  • 摘要: 原发性肝细胞肝癌(HCC)合并胆管癌栓临床少见,增强CT或磁共振成像检查可行临床 诊断,手术是其主要治疗手段。笔者报道1例HCC合并胆管癌栓术后复发病人采用免疫联合靶向治 疗的临床经验,其研究结果显示:肝内病灶缩小,效果良好。

     

    Abstract: Hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) is rare and enhanced CT or MRI can be used for its diagnosis. Surgical procedure is the main treatment for HCC with BDTT. The authors introduce the experiences of recurrent patient with HCC and BDTT who was treated with targeted therapy plus immunotherapy, in order to provide reference for its clinical diagnosis and treatment.

     

/

返回文章
返回